Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q1 2024 ▲▼ | Q2 2024 ▲▼ | Change ▲▼ | Q1 2024 ▲▼ | Q2 2024 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Nuvation Bio Inc.CL A(NUVB) | 14,072,340 | 13,275,884 | -796,456 | $51.22M | $38.77M | 28.72% | -$12.46M |
| Lexeo Therapeutics, Inc.(LXEO) | 2,355,904 | 2,355,904 | 0 | $36.94M | $37.79M | 28.00% | +$848.1K |
| Replimune Group, Inc.(REPL) | 3,001,319 | 2,461,319 | -540,000 | $24.52M | $22.15M | 16.41% | -$2.37M |
| enGene Holdings Inc. COM | 1,076,357 | 1,076,357 | 0 | $18.24M | $10.15M | 7.52% | -$8.09M |
| Alumis Inc | 0 | 653,225 | +653,225 | $0 | $8.69M | 6.44% | +$8.69M |
| Morphic Holding | 159,846 | 159,846 | 0 | $5.63M | $5.45M | 4.03% | -$180.6K |
| Sana Biotechnology, Inc.(SANA) | 843,750 | 843,750 | 0 | $8.44M | $4.61M | 3.41% | -$3.83M |
| Ikena Oncology | 2,249,123 | 2,249,123 | 0 | $3.19M | $3.71M | 2.75% | +$517.3K |
| Immunic, Inc.(IMUX) | 1,788,160 | 1,788,160 | 0 | $2.36M | $1.98M | 1.47% | -$375.5K |
| Syros Pharmaceuticals | 251,270 | 251,270 | 0 | $1.34M | $1.30M | 0.96% | -$47.7K |
| enGene Holdings Inc.WARRANT *W EXP 10/31/202 | 360,903 | 321,502 | -39,401 | $1.88M | $382.6K | 0.28% | -$1.49M |
| Kronos Bio | 955,866 | 0 | -955,866 | $1.24M | $0 | — | -$1.24M |